In our previous study, we screened the anti-cancer properties of 10 benzothiazole derivatives in cervical cancer cell lines. In the present study, we aimed to delineate the mechanism of the apoptotic pathway (whether intrinsic or extrinsic) following the treatment of N-(4-(benzo[d]thiazol-2-yl)phenyl)-5-chloro-2-methoxybenzamide (named as A-07) on cervical cancer cell lines. Cellular stress by reactive oxygen species was measured using DCFDA dye by flowcytometry. Protein expression and localization was checked by immunofluorescence for γH2A.X, TP53, and CASP-3. Expression profiles of BAX and BCL-2 was done by semi-quantitative RT-PCR and PARP-1 (Poly(ADP-ribose) polymerase-1) by Western blot analysis. Bioinformatic studies were done using PDB websites, metaPocket 2.0 server, YASARA software and Discovery Studio 3.5 Visualizer. We demonstrate that the compound A-07 leads to ROS generation and double strand breaks in SiHa and C-33A cells. The induction of apoptosis in SiHa cells is associated with increased nuclear expression of the tumor suppressor protein, TP53. The shift in BAX/BCL-2 ratio, increased expression of Caspase-3 and cleaved Poly(ADP-ribose) polymerase-1 favour apoptotic signal in SiHa. In silico studies revealed that A-07 has inhibiting capabilities to the E6/E6AP/P53 complex. Our data suggest that treatment of A-07 causes p53 and caspase dependent apoptosis in HPV 16 infected SiHa cells.
Introduction
More than 90% of cervical cancer cases are associated with Human Papillomavirus (HPV) and HPV 16 is involved in more than half of these cases [1, 2] . HPV early gene products, the oncoproteins E5, E6 and E7, contribute to cell proliferation and cell survival and modulate keratinocyte differentiation [3] . The E6 oncoprotein promotes ubiquitinylation and proteasomedependent degradation of TP53 via formation of a trimeric complex including E6, TP53, and E6-AP [4] . The contemporary anti-HPV drugs include oral hormonal medicine such as acyclovir, ganciclovir, interferon and interleukin. Since these drugs are expensive and their prolonged use may lead to liver and kidney damage [5] , an alternative therapeutic intervention is required.
The tumor suppressor TP53, a stress sensor, regulates cell cycle arrest, senescence, apoptosis and DNA repair. Cellular insults lead to rapid phosphorylation at N-terminus sites of TP53 mediated by different kinases including ATM, ATR, CHK1, CHK2, JNK, VRK1, PLK3, and CK1. Activated TP53 selectively regulates the transcription of more than 200 genes [6] . While the HPV-negative human cervical cancer cell line C-33A expresses high level of mutant TP53 [7] , the HPVpositive human cervical cancer cell line SiHa shows E6-mediated degradation of TP53 which is functionally equivalent to p53 inactivation through mutation [8] . The p53 gene is mutated in approximately 80% of the patients with triple negative breast cancer, and is a potential therapeutic target for patients with this form of breast cancer [9] .
There are reports that both vector-borne and synthetic siRNAs against HPV E6 can restore tumor-suppressor pathways in HPV-positive cells [10] . Determination of E6 target sequences of siRNA is important; strongest the RNAi activity towards cancer cells more applicable is the strategy clinically [11] . HPV E6 has been targeted with several peptide aptamers which led to apoptotic elimination of HPV16-positive cancer cells while HPV-negative cells were unaffected [12] . The TP53 binding cleft could also be a target for drugs that may lead to efficient disruption of the E6/E6AP/TP53 complex [13] . Bioinformatically, a drug named Rita, targeted the complex of E6, E6AP and TP53 and rescued the function of tumor suppressor p53 [14] .
Many small molecules like leptomycin B, and actinomycin D lead to the accumulation TP53 in the nucleus of HeLa, CaSki, and SiHa cells [15] . While TP53 directly induces BAX transcription, p53 mediated apoptosis is attenuated in the absence of Bax [16] . On activation, BAX oligomerizes with BAK and causes mitochondrial outer membrane permeabilization (MOMP). Cytochrome c, apoptotic proteaseactivating factor-1 (APAF-1), dATP and procaspase-9 forms the apoptosome after MOMP event (intrinsic pathway). Caspase cascade is activated within apoptosome leading to activation of caspase-3 [17] . Active caspase-3 cleaves Poly(ADP-ribose)polymerase-1 (PARP-1) which is the hallmark of apoptosis [18] . Many novel high-risk HPV-specific inhibitors are known to inhibit PARP1 [19] .
Production of reactive oxygen species (ROS) by nonenzymatic or enzymatic mechanisms can promote cell proliferation and survival, induce transient or permanent cell cycle arrest or induce mutations in DNA eventually leading to cancer depending on the level of oxidative stress [20] [21] [22] . Since oxidative stress causes DNA strand breaks and leads to apoptotic cell death [23] , characterization of agents that can increase intracellular ROS production may help in elimination of the cancer cells. DNA Double Strand Breaks (DSBs) induce phosphorylation of H2A.X at serine 139 (γH2A.X formation) in cells. Some drugs generate DNA lesions, which subsequently get converted into DSBs in the cells [24] . The cell sensors sense the DNA damage, stimulate DNA repair mechanisms and activate cell cycle checkpoints. The secondary response to DNA damage is apoptosis to protect the multicellular organism against the damaged cells [25] .
The benzothiazole treatment to cells results in generation of DNA lesions [26] . In an effort to investigate anticancer therapeutic potential of benzothiazole we screened its ten 2-phenyl substituted amide derivatives in cervical cancer cell lines SiHa (HPV16 positive) and C-33A (HPV negative) [27] . On the basis of cytotoxic efficacy we chose A-07 from the series for further characterization. In an effort to identify the molecular pathway regulating the apoptosis caused in these cell lines following A-07 treatment we have examined the cellular stress in cervical cancer cells and expression profiles of multiple apoptosis regulators in this study.
Materials and methods

Cell culture and drug treatment conditions
SiHa and C-33A cells were purchased from NCCS, Pune and were maintained in DMEM (CELL clone) with 10% FBS 
ROS detection
100,000 cells were seeded and A-07 treatment was done as described in section 2. Immunofluorescence 1000 cells were seeded on sterilized coverslips in 6 well plates (NEST, Thermo Fisher Scientific). Following the treatment of A-07 at standard conditions, the wells containing coverslip were washed with PBS, fixed with chilled methanol and blocked. Cells were incubated overnight with anti-γH2A.X antibody (p-Ser 139, Abcam, 1:500), anti-TP53 antibody (Neomarkers Fremont CA, 50:1000), and anti-CASP-3 antibody (Abcam, 1:500) at 4°C respectively followed by rinsing of the cells thrice with PBS and detection with FITC tagged secondary antibody (1:1500) in dark for 3 h. Cells were counterstained with DAPI after rinsing with 1 × PBS. The coverslips were mounted with DABCO (Sigma) over pre-cleaned slides, observed using 63× objective under a confocal microscope (Zeiss LSM 700) and photographed. γH2A.X foci were counted using ImageJ software and statistical analysis was done using GraphPad Prism 5 software.
Semi quantitative RT-PCR
100,000 cells were seeded and A-07 treatment was done as described in section 2.1. Cells from control and treatment groups were harvested following the treatment of A-07 at standard conditions. RNA was isolated using TRIzol (Thermo Fisher Scientific), quantified and used for cDNA synthesis (Applied Biosystems kit, Invitrogen). Primers were designed using Primer3 software and UCSC In-Silico PCR web server as listed in Table 1 . Each primer pair recognized at least one exon/intron junction to avoid amplification of genomic DNA. Bax, Bcl-2, and β-actin primers were used for PCR (S1000 Thermo cycler, Bio-Rad). The bands were visualized by AlphaImager EC and IDV ratio was calculated. Each experiment was repeated twice. Statistical analyses were done using GraphPad Prism 5 software.
Western blot
Following the A-07 treatment, total protein from control and treated cells was extracted using RIPA buffer (Sigma). 10 μl of each protein sample was electrophoresed and stained with Coomassie Brilliant Blue for checking the total protein integrity on 10% SDS PAGE. 50 μg of good quality total protein was loaded for electrophoresis on 8% SDS PAGE and was transferred on PVDF membrane (Merck Millipore). The membrane was blocked by 5% skimmed milk for one hour followed by incubation with anti-PARP1 antibody (CST, 1:1000) for 4 h at 4°C. The membrane was then washed thrice with 1 × TBST and incubated with ALP-tagged secondary antibody (Genei, 1:1000) followed by three washes with 1 × TBST. The membrane was then exposed to the substrate BCIP-NBT (ThermoFisher Scientific) for 10 min and scanned. A parallel 12% SDS PAGE was electrophoresed and used for anti-GAPDH (Imgenex, 1: 1000) detection.
Docking studies
The SDF file of Ligand (Drug A-07) was converted in Protein Data Bank (PDB) format. Receptor crystal structure of human papillomavirus oncoprotein E6 (PDB ID: 4GIZ) was downloaded from PDB server. Another receptor crystal structure of TP53 was retrieved from PDB under accession number 4XR8. The quality of retrieved model structures was checked using PDBSum website (PROCHECK) and Ramachandran Plot was analyzed for estimation of favoured regions. Active sites of selected receptors were identified using metaPocket 2.0 server. Further docking calculation was done using YASARA software and docking complex were visualized with Discovery Studio 3.5 Visualizer. The binding energy, dissociation constant and contacting receptor residues results are shown in Table 2 . The compound with more positive binding energy shows more interaction with the receptor.
Result
A-07 treatment induces cellular stress and DNA damage
To estimate the production of ROS following the treatment with A-07 we used cell permeable fluorescent DCFDA dye. The Geo mean increased from 8.01 to 34.08 following the A- (Fig. 1a) and the overlay histogram (Fig. 1b) show the shift of cell population towards right on FL-1 (X-axis) channel. This marks the cell population with increase of ROS production in treated groups. To investigate whether ROS produced following A-07 treatment induces DNA damage we studied the phosphorylation of H2A.X (γH2A.X). Our immunofluorescence data for γH2A.X demonstrate significant increase in foci formation in treated groups of SiHa (p value = 0.023) and C-33A (p value = 0.032) (Fig. 1c, d ) suggesting induced DNA DSBs.
Induction of intrinsic apoptotic machinery by A-07
The most common molecules involved in apoptosis are Bax and Bcl-2. Analysis of semi-quantitative RT-PCR demonstrate increase in mRNA expression ratio in both the cell lines (Fig. 2a) , however, the differential expression is significant only in SiHa (p value = 0.013) and not in C-33A (p value = 0.068) (Fig. 2b) following the treatment of A-07. Among many, one of the downstream molecules to Bax and Bcl-2 is Caspase-3. Our immunofluorescence data using CASP-3 antibody following the treatment of A-07 show increased localization of CASP-3 in SiHa (p value = 0.018) but not in C-33A (p value = 0.773) (Fig. 3a, b and c) . Thus, following administration of A-07 caspase-dependent apoptosis occurs in SiHa. Interestingly, our western blot analysis suggests CASP-3 mediated PARP-1 cleavage in SiHa but not in C-33A following the treatment of A-07 (Fig. 2c) . Evaluation of TP53 by 
Discussion
Benzothiazole derivatives are privileged heterocyclic scaffold having diverse pharmaceutical applications. They are recently being used for treatment and prevention of various tumors. Cellular stress may be an early event in the activation of the apoptotic machinery. Similar to the recent reports that treatment of these compounds can increase the levels of ROS and subsequently lead to DNA damage [28] [29] [30] , our data suggests that A-07 treatment leads to generation of ROS and DNA damage in SiHa and C-33A cells. Since the correlation between DNA DSBs and γH2A.X foci is established to be 1:1 ratio [31] , increase in γH2A.X foci in A-07 treated cell lines in our study suggests induction of DSBs. Persistent DNA damage by DSBs can lead to apoptotic cell death [32] and evading apoptosis is one of the hallmarks of cancer. BCL-2 protein family plays an important role in the regulation of mitochondrial apoptosis pathway. A benzothiazole derivative YLT322 treatment to cells has increased the expression of BAX and decreased the expression of BCL-2 leading to intrinsic apoptosis both in vitro and in vivo [33] . Following A-07 treatment we found significant increase in differential BAX/BCL-2 mRNA ratio between treated and untreated groups in SiHa and not in C-33A. While both C-33A and SiHa cells have epithelial morphology, C-33A is HPV negative cell line and SiHa has HPV16 infection. Also, C-33A has a point mutation in p53, at codon 273 resulting in Arg-> Cys substitution. These results suggest role of TP53 in the differential response of these two cervical cancer cell lines upon treatment with A-07.
Among the different caspases, caspase-3 (CASP-3) is considered to be a crucial part of apoptosis machinery. Benzothiazole containing phthalimide causes both caspasedependent and -independent apoptosis in cancer cells [34] . Since, both SiHa and C-33A show cellular stress, DNA damage and apoptosis, we further investigated CASP-3 by immunofluorescence in SiHa and C-33A. While there is a significant increase of CASP-3 cytoplasmic expression in SiHa Fig. 7 Mechanism of anti-cancer action of A-07 on SiHa and C-33A cells treated with A-07, C-33A did not show significant differential fluorescence for CASP-3. Our results thus suggest that apoptosis in SiHa is caspase-dependent and in C-33A it is caspase-independent in response to A-07. Ramuz et al. has demonstrated that active CASP-3 initially appears in the cytoplasm at early stages of apoptosis and appears later in the nucleus [35] . This further supports that the CASP-3 in A-07 treated cells are in active form.
Active caspase-3 translocates in nucleus and is known to cleave PARP1 [36, 37] . PARP-1 is a chromatin-bound nuclear enzyme which modifies various nuclear proteins by poly(ADP-ribosyl)ation and is also involved in regulation of the molecular events involved in the recovery of cell from DNA damage [38] . Many PARP inhibitors have been identified as chemo-and radiation-sensitizing agents in multiple cancers [39] . Demonstration of PARP cleavage induced by benzothiazole based conjugates [40] supports our findings in SiHa cells treated with A-07 which show caspase-mediated PARP cleavage. However, C-33A treated with A-07 did not show effect on PARP expression in western blot analysis suggesting caspase-independent apoptosis in these cells. While caspases are downstream to Bax/Bcl-2 [41] , TP53 is upstream as transcription factor for Bax [42, 43] . In mitochondrial apoptotic pathway, TP53 interacts with BAX in a proposed 'hit and run' manner [44] and regulates expression and activation of BAX. C-33A is a TP53 mutant cell line and lacks p53 mediated apoptosis further validates our results.
Since SiHa is HPV16 infected and the E6/E6AP/p53 complex causes HPV-mediated degradation of p53 [13] , our observation of increased nuclear expression of TP53 in SiHa treated with A-07 is interesting. Some of the earlier reports demonstrating that there are molecules that can interrupt the E6-AP complex and prevent the effective degradation of TP53 [10] [11] [12] 15] may be the most plausible explanation for our results. A group demonstrated that restoration of gene GRIM-19 impedes the E6/E6AP complex and prevents p53 degradation in xenograft mouse model, ultimately increasing apoptosis [45] . TP53 is activated by external and internal stress signals that promote its nuclear accumulation in an active form. The activation of TP53 leads to cell growth arrest, senescence or apoptosis, depending on the threshold of insult by cellular stress. Hence, reconstitution of inactive p53-dependent apoptotic pathways is an attractive approach currently being explored as anti-cancer treatment [46, 47] .
We used bioinformatic tools to find out the interaction between A-07, E6 and TP53 by molecular docking which helps to do pose prediction, virtual screening and binding affinity estimation. Satisfactory docking results can be obtained when relatively small ligands with a few rotatable bonds are docked against protein binding pocket [48] . A report using bioinformatic tools demonstrated that Nicandrenone can be used as a candidate drug against HPV induced cervical cancer [49] . In our study we took A-07 PDB format as ligand and receptor crystal structure of human papillomavirus oncoprotein E6 and tumor suppressor protein TP53 were used for docking. We then determined the stereo-chemical structure quality of these receptors by Ramachandran plot and Procheck statistics. We found that various residues of E6 and TP53 interact with A-07. In conclusion, A-07 can interrupt the E6/E6AP/p53 complex leading to inefficient degradation of TP53 and p53 mediated intrinsic apoptosis in SiHa. The possible differential mechanisms of apoptosis in HPV-positive and HPV-negative cervical cancer cells has been summarized by a flowchart (Fig. 7) .
